Listen

Products

Transparency

SAWAI's Product Lines

Representative Sawai Value-added Innovations marketed in Japan

Drug usability is an important issue in Japan. At Sawai, we address a diverse range of patient needs using the following methods and devices to improve drug bitterness, shape, delivery and more.

Design of products
easily taken by patients

Change of dosage form

Reformulation of large, hard-to-swallow capsules into tablets

Smaller sized tablets

Resizing large, hard-to-swallow tablets into smaller tablets

OD tablets

Development of Orally Disintegrating Tablets

Enchancements that facilitate prescription
and dispensing for healthcare providers

Easy to split

Scored tablets easy to split

Improved stability

Improved stability against humidity, temperature, light etc.

Improvements of safe medication practices based
on reducing medical errors

Better containers

New, high-safety containers that protect against breakage

Pre-filled syringes / Pre-mixed bags

Switch to ready-to-use medical products

Clear displays

Clear descriptions of drug names, and effects included in packaging

Around 300 high-quality generic drugs with around 700 strengths

Various forms of medication

  • Tablets
  • Oral dispersing tablets
  • Capsules
  • Granule
  • Injectables
  • Tape
  • Ophthalmic / nasal solution
  • Syrup etc.

Covering all therapeutic areas

  • Cardiovascular
  • Gastro-intestinal
  • Blood / body fluid
  • Other metabolic
  • Antibiotics
  • Central nervous system
  • Antiallergics
  • Chemotherapeutics
  • Vitamins
  • Anti-cancer etc.

Principal Products

Active Ingredient Name Therapeutic Category Dosage Form Strength
ATORVASTATIN Cardiovascular agents Tablets 5mg / 10mg
LIMAPROST ALFADEX Cardiovascular agents Tablets 5μg
CLOPIDOGREL Blood/body fluid agents Tablets 32.63mg / 65.24mg / 97.88mg
LANSOPRAZOLE Digestive organ agents Orally disintegrating tablets 15mg / 30mg
RALOXIFENE HYDROCHLORIDE Other metabolic drugs Tablets 60mg
Active Ingredient Name ATORVASTATIN
Therapeutic Category Cardiovascular agents
Dosage Form Tablets
Strength 5mg / 10mg
Active Ingredient Name LIMAPROST ALFADEX
Therapeutic Category Cardiovascular agents
Dosage Form Tablets
Strength 5μg
Active Ingredient Name CLOPIDOGREL
Therapeutic Category Blood/body fluid agents
Dosage Form Tablets
Strength 32.63mg / 65.24mg / 97.88mg
Active Ingredient Name LANSOPRAZOLE
Therapeutic Category Digestive organ agents
Dosage Form Orally disintegrating tablets
Strength 15mg / 30mg
Active Ingredient Name RALOXIFENE HYDROCHLORIDE
Therapeutic Category Other metabolic drugs
Dosage Form Tablets
Strength 60mg

Volume Composition According to Classification of Drugs by Therapeutic Category (As of March 2019)

Transparency